DK127332B - Analogous process for the preparation of therapeutically effective 1-substituted 2 [1H] -quinazolinones. - Google Patents
Analogous process for the preparation of therapeutically effective 1-substituted 2 [1H] -quinazolinones.Info
- Publication number
- DK127332B DK127332B DK603267A DK603267A DK127332B DK 127332 B DK127332 B DK 127332B DK 603267 A DK603267 A DK 603267A DK 603267 A DK603267 A DK 603267A DK 127332 B DK127332 B DK 127332B
- Authority
- DK
- Denmark
- Prior art keywords
- quinazolinones
- substituted
- preparation
- therapeutically effective
- analogous process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
- C07D239/82—Oxygen atoms with an aryl radical attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR85985A FR6001M (en) | 1966-12-02 | 1966-12-02 | |
FR97203A FR1520743A (en) | 1966-12-02 | 1967-03-02 | Novel substituted quinazolinones and method of preparation |
FR106810A FR6158M (en) | 1966-12-02 | 1967-05-18 | |
FR125422 | 1967-10-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK127332B true DK127332B (en) | 1973-10-22 |
Family
ID=27444746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK603267A DK127332B (en) | 1966-12-02 | 1967-12-01 | Analogous process for the preparation of therapeutically effective 1-substituted 2 [1H] -quinazolinones. |
Country Status (7)
Country | Link |
---|---|
CH (1) | CH482685A (en) |
DE (1) | DE1695656B2 (en) |
DK (1) | DK127332B (en) |
FR (3) | FR6001M (en) |
GB (1) | GB1181570A (en) |
IL (1) | IL28991A (en) |
NL (1) | NL6716429A (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3923803A (en) * | 1968-07-18 | 1975-12-02 | Sumitomo Chemical Co | 2(1H)-Quinozalinones and process therefor |
DE1932402C3 (en) * | 1969-06-26 | 1981-09-03 | Sandoz-Patent-GmbH, 7850 Lörrach | 1-Isopropyl-4-phenyl-3,4-dihydro-2 (1H) quinazolinone derivatives and their further processing to 1-isopropyl-4-phenyl-2 (1H) quinazolinones |
DE2118315C3 (en) * | 1970-04-20 | 1975-04-03 | Sumitomo Chemical Co., Ltd., Osaka (Japan) | 2- (1H) -quinazolinone derivatives, processes for their preparation and pharmaceuticals containing these compounds |
US3764600A (en) * | 1970-10-06 | 1973-10-09 | Sandoz Ag | 1-substituted-quinazoline-2(1h)-thiones |
US3925549A (en) * | 1970-10-06 | 1975-12-09 | Sandoz Ag | 1-Substituted-quinazoline-2(1H)-thiones in the treatment of inflammation |
US4071516A (en) | 1976-08-20 | 1978-01-31 | Sandoz, Inc. | 4-(Acyloxyphenyl)-quinazolin-2(1H)-ones |
AR038658A1 (en) | 2001-06-15 | 2005-01-26 | Novartis Ag | DERIVATIVES OF 4-ARIL-2 (1H) QUINAZOLINONA AND 4-ARIL-QUINAZOLINA 2-SUBSTITUTES, A PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH DERIVATIVES FOR THE PREPARATION OF A MEDICINAL PRODUCT |
GB0230015D0 (en) | 2002-12-23 | 2003-01-29 | Novartis Ag | Organic compounds |
ES2630062T3 (en) * | 2012-04-10 | 2017-08-17 | Annji Pharmaceutical Co., Ltd. | Histone Deacetylase Inhibitors (HDAC) |
-
1966
- 1966-12-02 FR FR85985A patent/FR6001M/fr not_active Expired
-
1967
- 1967-03-02 FR FR97203A patent/FR1520743A/en not_active Expired
- 1967-05-18 FR FR106810A patent/FR6158M/fr not_active Expired
- 1967-11-21 IL IL2899167A patent/IL28991A/en unknown
- 1967-11-23 CH CH1645167A patent/CH482685A/en not_active IP Right Cessation
- 1967-12-01 DE DE1967R0047487 patent/DE1695656B2/en active Granted
- 1967-12-01 DK DK603267A patent/DK127332B/en not_active IP Right Cessation
- 1967-12-01 NL NL6716429A patent/NL6716429A/xx unknown
- 1967-12-04 GB GB55090/67A patent/GB1181570A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE1695656A1 (en) | 1972-04-13 |
FR6158M (en) | 1968-07-01 |
FR6001M (en) | 1968-04-29 |
DE1695656B2 (en) | 1974-06-06 |
NL6716429A (en) | 1968-06-04 |
DE1695656C3 (en) | 1979-12-06 |
IL28991A (en) | 1972-11-28 |
CH482685A (en) | 1969-12-15 |
FR1520743A (en) | 1968-04-12 |
GB1181570A (en) | 1970-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK128353B (en) | Analogous process for the preparation of therapeutically active bis-chromones. | |
FI48590C (en) | Process for the preparation of therapeutically useful azaspiroalkandion compounds. | |
DK137854B (en) | Analogous process for the preparation of 2-nitroimidazole derivatives. | |
FI45970C (en) | Process for the preparation of therapeutically valuable 1-substituted-2-aryl-4- or 5-nitroimidazoles. | |
DK113645B (en) | Process for the preparation of therapeutically effective indolyl-3-alkane-carboxylic acids. | |
DK127332B (en) | Analogous process for the preparation of therapeutically effective 1-substituted 2 [1H] -quinazolinones. | |
DK115400B (en) | Process for the preparation of therapeutically effective 3-keto-19-alkyl-androstanes. | |
FI47986C (en) | Process for the preparation of therapeutically active 2,3-dihydro-1H-1,4-benzodiazepin-2-ones | |
DK121708B (en) | Analogous process for the preparation of therapeutically effective 22-aza-cholesterol derivatives. | |
FI45041C (en) | Process for the preparation of therapeutically useful pyrrole derivatives. | |
DK130115B (en) | Analogous process for the preparation of 1-substituted 2 (1H) -quinazolinones. | |
DK117635B (en) | Analogous process for the preparation of therapeutically active 3- (piperazinoalkyl) -pyrazoles. | |
FI45551C (en) | Process for the preparation of therapeutically useful dehydroepiandro osterone monanthate. | |
DK131429B (en) | Analogous process for the preparation of derivatives of 4'-demethyl-epipodophyllotoxin-beta-D-glucoside. | |
DK122760B (en) | Analogous process for the preparation of therapeutically active 4-alkoxy-3,5-dimethoxybenzamides. | |
DK120399B (en) | Analogous process for the preparation of therapeutically effective phenylalanine derivatives. | |
DK125891B (en) | Analogous process for the preparation of nitroimidazoles. | |
FI47092C (en) | Process for the preparation of therapeutically valuable mixture-substituted 1-phenoxy-3-alkylaminopropanols- (2). | |
DK123764B (en) | Analogous process for the preparation of acid amides. | |
FI47358C (en) | Process for the preparation of therapeutically useful 4'-demethyl-epi podophyllotoxin-beta-D-glucoside. | |
FI46966C (en) | Process for the preparation of therapeutically useful 1,3-dihydro-3-hydroxy-1,4-benzodiazepin-2-ones | |
DK117488C (en) | Process for the preparation of therapeutically active 2α-3α-epithio-5α-androstanes. | |
DK116658B (en) | Process for the preparation of therapeutically active 7α-methyl-Δ <5> -estrenes. | |
DK103778C (en) | Process for the preparation of 1-substituted cycloheptimidazole-2- (1H) -one compounds. | |
DK122223B (en) | Analogous process for the preparation of therapeutically active biphenyl compounds. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |